Jeffrey Borcherding

Chairman & CEO

C-suiteM

FI·FIN-FSA

Immunovia AB (publ)Immunovia AB (publ)

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Jeffrey Borcherding, Chairman & CEO. Director active across 2 companies, notably Immunovia AB (publ). Cumulatively, 1 filings have been logged. The latest transaction was filed on 22 May 2025 — Purchase. Regulator: FIN-FSA. The full history is free.

Declarations1 total

Executives●PurchaseIImmunovia AB (publ)23FIN-FSA

J

Jeffrey BorcherdingVerkställande direktör (VD)

03,139,314 shares0

Option

FI:A003P269-1·22 May 2025

Ideal exit: 16 Feb 2026 (T+270)

FIN-FSA ↗

1 of 1 declaration

About Jeffrey Borcherding

Jeffrey Borcherding is the CEO of Immunovia AB (publ). In this role, he oversees daily operations and the implementation of the company's strategy. His experience in the biotechnology sector is essential for Immunovia.